Genomatica Wins 2013 Kirkpatrick Award SAN DIEGO, Sept. 26,

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Genomatica Wins 2013 Kirkpatrick Award

SAN DIEGO, Sept. 26, 2013 (GLOBE NEWSWIRE) -- Genomatica has been named the 2013 winner of the prestigious Kirkpatrick Chemical Engineering Achievement Award for its successful commercialization of its bio-based process for the production of 1,4-butanediol (BDO), a widely-used chemical. Awarded every other year since 1933 by Chemical Engineering magazine, the Kirkpatrick Award recognizes the most noteworthy chemical engineering technology commercialized anywhere in the world during the prior two years, and involves over 100 senior professors that head accredited university chemical engineering departments around the world. Genomatica joins a distinguished set of companies that have helped shape broad portions of the modern chemical industry.

Genomatica delivered a chemical engineering breakthrough in 2012 by producing BDO in a cost-competitive, 'direct' fermentation process at commercial scale from renewable feedstocks, while meeting demanding quality and economic specifications. Multiple large partners have validated the application usability of BDO made with Genomatica's process, including Lanxess , Toray and Far Eastern New Century , while BASF and Novamont have licensed Genomatica's process for renewable BDO. Genomatica has also successfully run its process at five sites worldwide, to date, validating the repeatability, consistency and transferability of its technology.

The Kirkpatrick Award's recognition of process maturity, commercial readiness and industry significance shine a spotlight on Genomatica as a technology-focused enabler for the mainstream chemical industry with new, advantaged process technologies and the core engineering strengths to apply its advanced science to real production plants. This award complements extensive recognition from the scientific community, highlighted by the EPA Presidential Green Chemistry Challenge Award ; from industrial biotech by being voted #1 Hottest two years in a row by Biofuels Digest readers; from chemical industry and business experts for innovation, from both ICIS and the Wall Street Journal ; and for corporate culture, as a Best Place to Work , twice, by The Scientist.

"Winning the Kirkpatrick Award confirms that our process technology works; our economics work; and our overall process engineering, scale-up and technology transfer work," said Christophe Schilling, Ph.D., CEO of Genomatica. "Our first process, for BDO, is ready for widespread deployment and use and we're championing the product value chains that will benefit from the BDO made by licensees using our process. We're looking forward to applying the same disciplined development and industrial-scale engineering to deliver processes for multiple additional widely-used chemicals."

About Genomatica

Genomatica is a widely-recognized technology leader for the chemical industry. It develops manufacturing process technologies that enable its licensee partners to produce the world's most widely-used chemicals a 'better way,' from renewable feedstocks, with better economics and greater sustainability than petroleum-based processes.

Genomatica's first process, for BDO, is now commercial. Genomatica's BDO process was used to make 5 million pounds of BDO in late 2012; and has been licensed by BASF and by Novamont. Multiple companies, including Lanxess , Toray and Far Eastern New Century , have confirmed that BDO produced using Genomatica's BDO process can be used the exact same way for downstream products as chemicals made from fossil fuel feedstocks, simplifying and accelerating adoption. Genomatica is developing processes for additional major chemicals; the next is for butadiene , with Versalis as partner.

Genomatica's recognition includes the Wall Street Journal Technology Innovation award , ICIS Top 40 ' Ones to Watch ,' the EPA Presidential Green Chemistry Challenge Award , and being voted #1 Hottest two years in a row by Biofuels Digest.

For Genomatica: Rob Adler, , 415.984.1970 x0104

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 7

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
NARUTO Card Game Set for June 2027 Global Launch

Updated Category News Views 8

Mark Your Calendars: Global Launch June 2027 They're rolling out a red carpet for nostalgia here, I tell ya! At the New York Comic Con, BANDAI announced a worldwide launch for the NARUTO CARD GAME in June 2027. We'll see pre-built decks starring your favorite shinobi and a mad sprint to collect with the new booster packs. Feels sort of like they’re summoning a jutsu...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 2

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
Phase I of 2026 Hong Kong Trade Shows Highlights Innovation

Updated Category News Views 6

Hong Kong Takes Center Stage in Global Commerce Flip through the economic landscape today, and you’ll spot Hong Kong, decked out in its best as a trade linchpin—with over 2,100 suppliers gathered under one roof. AsiaWorld-Expo is buzzing with the commencement of Phase I of the October 2026 Global Sources Hong Kong Shows. The theme's all about 'Connecting Global...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 4

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 2

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 3

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 4

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 2

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
AI Drives Major Time Savings in Endoscopy Tech

Updated Category News Views 9

AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...

Continue Reading

Top 5 Most Recently Viewed Articles

Earnings Season Highlights: Constellation, Delta, and Walgreens

Updated Category News Views 182

Earnings Season Highlights: Key Companies Preparing to Report The financial markets are buzzing as earnings season continues. This is an exciting time for investors and analysts alike as companies unveil their financial performance. On the horizon are a few major players that are set to announce their earnings. Notably, Constellation Brands (NYSE: STZ), Delta Air Lines...

Continue Reading
Mitek Plans Conference Call for Fiscal First Quarter Results

Updated Category News Views 98

Mitek Plans Conference Call for Fiscal First Quarter Results Mitek Systems, Inc. (NASDAQ: MITK), a leading player in digital identity verification and mobile capture technologies, is set to announce its financial results for the first quarter of the fiscal year. The financial information will be publicly released on an upcoming Monday, shortly before a conference call...

Continue Reading
ABN AMRO and Blackstone Forge Strategic Risk Transfer Deal

Updated Category News Views 191

ABN AMRO and Blackstone Collaborate on Risk Management In a notable development in the financial sector, ABN AMRO has successfully executed a significant risk transfer (SRT) transaction with funds managed by Blackstone. This strategic collaboration aims to enhance ABN AMRO's growth potential while effectively managing substantial corporate loan portfolios. The...

Continue Reading
Analyzing Williams Companies: P/E Insights and Implications

Updated Category News Views 113

Understanding the P/E Ratio of Williams Companies Currently, the stock of Williams Companies Inc. is trading at $59.89, reflecting a 0.40% increase in its price. Over the past month, the stock has surged by 15.07%, and in the past year, it has shown impressive growth of 64.19%. Such substantial performance has left long-term shareholders feeling quite optimistic. However,...

Continue Reading
Miami International Holdings Set to Launch Futures Trading Soon

Updated Category News Views 242

Miami International Holdings Plans Financial Futures Launch Miami International Holdings, Inc. (NYSE: MIAX) is gearing up to enhance its trading platform with the introduction of financial futures on MIAX Futures™. This strategic move marks a significant milestone for the company and is anticipated to offer traders new and exciting opportunities. Overview of MIAX...

Continue Reading